SLC16A1 and cancer: MCT1 inhibition can also block the uptake of lactate by oxidized cancer cells to stromal cells, impairing the promotion of cancer cell proliferation by CAFs and the angiogenesis induced by lactate on endothelial cells (Vegran et al., 2011).